The exploration of iparomlimab and tuvonralimab combined with de−escalated chemotherapy as an innovative neoadjuvant treatment strategy for locally advanced cervical cancer: a case report from the NICE-CC trial
Recent research has explored the potential of using neoadjuvant dual immune checkpoint inhibitors (ICIs) combined with de−escalated chemotherapy in several locally advanced tumors to determine if such a combined regimen can enhance tumor response while…